Meloknot 15 Tablet contains Meloxicam 15mg, a preferential COX-2 inhibiting non-steroidal anti-inflammatory drug (NSAID) indicated for the management of chronic inflammatory conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and musculoskeletal pain. It helps in reducing joint pain, stiffness, and swelling while improving mobility.
Meloxicam works by inhibiting cyclooxygenase enzymes involved in prostaglandin synthesis, thereby reducing inflammation and pain with a comparatively better gastrointestinal tolerability profile than traditional NSAIDs. This makes it suitable for long-term management of inflammatory joint disorders.
For distributors and healthcare suppliers, Meloknot 15 Tablet is a high-rotation anti-inflammatory and analgesic product, widely prescribed by orthopedists, rheumatologists, and general physicians. The rising prevalence of arthritis and age-related joint disorders ensures sustained and recurring demand.
Adding Meloknot 15 Tablet to your pain management and anti-inflammatory therapy segment creates strong opportunities in pharmacies, hospitals, orthopedic clinics, export markets, and third-party manufacturing. Its proven efficacy, chronic-use suitability, and strong prescriber acceptance make it a valuable addition to pharmaceutical distribution portfolios.